Skip to content

Updates

Explore our latest insights, regulatory updates, and strategic reports for the life sciences sector.

Food and Feed Litigation Regulatory Compliance and Enforcement Testimonial

We have advised a company on defending itself against an enforcement action brought by the Netherlands Food and Consumer Product Safety Authority (NVWA).

Litigation Testimonial

We have represented clients in complex commercial litigation proceedings, including claims relating to earn-out disputes in the context of corporate transactions in the life sciences sector.

Litigation Testimonial

Our firm litigates before the European Court of Justice on a variety of life sciences topics.

Medical Devices Litigation Testimonial

Our lawyers have acted as expert in national litigation cases on MDR compliance in other EU Member States.

Medical Devices Litigation Testimonial

One of our lawyers has acted as arbiter in international proceedings on MDR compliance.

Litigation Testimonial

Our firm is experienced in the conduct and defence of companies against freedom of information cases pertaining to confidential under Dutch and EU law, and has defended a number of companies, including a multinational, in a series of such cases over the years.

Healthcare Litigation Testimonial

We have assisted several clients in challenging tender decisions by Dutch hospitals.

Pharmaceuticals Litigation Regulatory Compliance and Enforcement Testimonial

We have litigated in a pharmaceutical case concerning the validity of marketing authorisations.

Food and Feed Medical Devices Pharmaceuticals Advertising and Claims Litigation Testimonial

We have advised several clients on the conduct and defence of complaints made to the Dutch Advertising Committee regarding claims about products such as foods, pharmaceuticals and medical devices across Dutch media.

Biotech Corporate, Governance and Boardroom Counselling Intellectual Property and Licensing Spin-out and Starter Advisory Testimonial

Axon regularly advises spin-outs from academic institutions on a wide range of topics. We make sure that the spin-out’s license agreement includes commercially and legally viable terms and is attractive to investors. In addition, we advise on the corporate structure of the spin-out, balancing the interest of the founders, the academic institution and all other stakeholders.